课题基金 / 基金详情

Enhancing Mechanism of Enhancers as a Basis for Delivery of Bioactive Peptides

Enhancing Mechanism of Enhancers as a Basis for Delivery of Bioactive Peptides
增强剂的增强机制作为生物活性肽递送的基础
批准号:
06453195
负责人:
NAKANO Masahiro
金额:
$3.97万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1996

项目摘要

项目成果

NAKANO Masahiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
When lidocaine is dissolved in an aqueous gel, the drug is absorbed well, and decreased pain when a needle is inserted through the skin for injection of human growth hormone.Al though diltiazem is absorbed through the gastrointestinal tract well, formulations which enable to absorb the drug fast through oral mucosa is required since absorption of diltiazem through the oral mucosa is not very efficient. High concentrations in the mouth caused by fast dissolution of the drug in the mouth are required to increase absorption from the mouth and to give enough concentrations in the blood.Amphotericin B with molecular weight of 924 is a large molecule and is poorly absorbed from the gastrointestinal tracts. In order to absorb the drug in a predictable fashion, some modification in formulation is necessary. Concentrations of the drug in the blood were measured both in adults and children and low in both.Effect of chitosan, a polysaccaride with amino groups, on nasal absorption of hydrophilic drugs was studied as a representative of basic polymers. Aqueous solubility is limited in high molecular weight chitosan, and moderately soluble chitosan samples weer examined. Riboflavin phosphate was used as a model of peptides because of its hydrophilic nature and its easy assay. Chitosan samples were obtained from several companies and four samples with high aqueous solubility were employed in the study. Effect of chitosan on absorption of riboflavin phosphate through nasal mucosa in rabbits was studied. Effect of concentrations of chitosan on enhancing absorption of riboflavin phosphate was studied in Chitosan C-9 because other samples were less soluble than this in water. Maximal enhancing effect was noted at 0.5% among 0.5,1, and 2%. Bioavailability of insulin was increased by chitosan.Egualen, a delivative of azulene was effective in increasing bioavailability of insulin and salmon calcitonin.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
中野眞汎: "DDSタイプ製剤の現状" 日本病院薬剤師会雑誌. 31(7-8). 821-824 (1995)
Masahiro Nakano:“DDS型制剂的现状”日本医院药剂师学会杂志31(7-8)821-824(1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
N.Iwatani,M.Kodama,T.Miike,T.Kano,M.Nakano,M.Mishima,O.Tsuzuki: "Dermal anesthesia using a lidocaine gel patch for pain of human growth hormone(hGH) self-injection and relief of anxiety" Clinical Pediatrics and Endocrinology. 3. 113-116 (1994)
N.Iwatani、M.Kodama、T.Miike、T.Kano、M.Nakano、M.Mishima、O.Tsuzuki:“使用利多卡因凝胶贴片进行皮肤麻醉,用于人类生长激素 (hGH) 自我注射和缓解疼痛
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.matsuo,C.Nakamura,K.Arimori,M.Nakano: "Evaluation of hydroxyethylcelluse as a hydroxyethylcelluse as a hydrophilic swellable material for delayed-release tablets" Chemical and Pharmaceutical Bulletin. 43. 311-314 (1995)
M.matsuo、C.Nakamura、K.Arimori、M.Nakano:“羟乙基纤维素作为缓释片剂的亲水性可膨胀材料的评估”化学和制药通报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Development of an automatic safety property prover with lemma discovery based on test
    Study on the quantum features of nuclear matter based on the non-perturbed
    Development of multiple emulsion to deliver drugs
    • 批准号:
      07557296
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $0.64万
    • 财政年份:
      1995
    • 负责人:
      NAKANO Masahiro
    • 依托单位:
    国内基金
    海外基金
    同源异形盒基因HvVvl介导20E信号通路和insulin信号通路调控茄二十八星瓢虫变态发育的分子机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      潘慧鹏
    • 依托单位:
    基于稳态吸收和DPP-IV/GLP-1/Insulin通路解析牡蛎肽协同花色苷的降血糖增效机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      陈忠琴
    • 依托单位:
    CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
    • 批准号:
      82370798
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      王晓
    • 依托单位:
    SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
    • 批准号:
      82371873
    • 项目类别:
      面上项目
    • 资助金额:
      50.00万元
    • 批准年份:
      2023
    • 负责人:
      乔洁
    • 依托单位: